This drug assists in the enhancement of glycemic regulation in adult patients who have a high level of hyperbolic acid (HBA1c) and/or are co-infected with other conditions. It will be priced at Rs 14 per tablet (per day).
Related Keywords
India ,Alok Malik ,Glenmark Pharma ,Glenmark Zita , ,Business Head ,India Formulations ,Glenmark ,Diabetes ,Co Morbidities ,Oita ,Iabetes Co Morbidities ,Type 2 Diabetes ,
comparemela.com © 2020. All Rights Reserved.